IL1RL1 and chronic obstructive pulmonary disease: Since IL1RL1 was initially discovered on Th2 cells91, which is elevated in asthma and chronic obstructive pulmonary disease (COPD), several neutralizing IL1RL1 antibodies (i.e., astegolimab) have been developed.